上海一研生物科技有限公司專業(yè)供應(yīng)各種抗體，根據(jù)客戶需求提供制備抗體，磷酸化原癌基因CBL2抗體*,保證磷酸化原癌基因CBL2抗體品質(zhì)。公司產(chǎn)品很多，詳細資料說明書請向銷售人員索取。
英文名稱  Anti-phospho-C CBL(Tyr700) 
中文名稱   
別    名  c-Cbl (phospho-Tyr700); C CBL; Cas Br M (murine) ecotropic retroviral transforming sequence; Cas-Br-M (murine) ecotropic retroviral transforming sequence; Casitas B lineage lymphoma proto oncogene; Casitas B-lineage lymphoma proto-oncogene; CBL 2; cbl; CBL_HUMAN; CBL2; E3 ubiquitin protein ligase CBL; E3 ubiquitin-protein ligase CBL; Oncogene CBL2; Proto oncogene c CBL; Proto-oncogene c-CBL; RGD1561386; RING finger protein 55; RNF55; Signal transduction protein CBL. 
濃    度  1mg/1ml 
規(guī) 格  0.1ml/100μg   
抗體來源  Rabbit  
克隆類型  polyclonal 
交叉反應(yīng)  Human, Mouse, Rat, Dog, Pig, Cow, Horse  
產(chǎn)品類型  一抗  磷酸化抗體   
研究領(lǐng)域  腫瘤 免疫學 轉(zhuǎn)錄調(diào)節(jié)因子 b-淋巴細胞  
蛋白分子量  predicted molecular weight: 100kDa 
性    狀  Lyophilized or Liquid 
免 疫 原  KLH conjugated synthesised phosphopeptide derived from human C CBL around the phosphorylation site of Tyr700 
亞    型  IgG 
純化方法  affinity purified by Protein A 
儲 存 液  0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soium zde 
公司的理念是：為您提供抗體及相關(guān)標記抗體性價比產(chǎn)品和*的服務(wù)。公司能夠及時解決和滿足客戶的各方面的需求，與國內(nèi)多家企業(yè)建立了良好的*合作關(guān)系，在市場上樹立了公司的良好信譽和形象。本公司是專業(yè)經(jīng)營免疫組化試劑盒，Elisa試劑盒，抗體，抗原，標記抗體，標記抗原，生化試劑的公司，在廣大用戶的幫助和支持下，經(jīng)過不懈的努力，已成為國內(nèi)生命科學領(lǐng)域產(chǎn)品的主要供應(yīng)商之一，代理許多*水平的高科技產(chǎn)品，包括分子生物學、細胞生物學、免疫學、診斷等多個研究及應(yīng)用領(lǐng)域。公司的服務(wù)和業(yè)務(wù)網(wǎng)絡(luò)遍及全國，在同行獲得*好評。
產(chǎn)品應(yīng)用   WB=1:100-500  ELISA=1:500-1000  IP=1:20-100  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500 
（石蠟切片需做抗原修復） 
 not yet tested in other applications.
 optimal dilutions/concentrations should be determined by the end user.  
保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 
產(chǎn)品介紹 Participates in signal transduction in hematopoietic cells. Adapter protein that functions as a negative regulator of many signaling pathways that start from receptors at the cell surface. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including PDGFA, EGF and CSF1, and terminates signaling.
Function : Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The Tyr-731 phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function.
Subunit : Interacts (phosphorylated at Tyr-731) with PIK3R1. Associates with NCK via its SH3 domain. The phosphorylated C-terminus interacts with CD2AP via its second SH3 domain. Binds to UBE2L3. Interacts with adapters SLA, SLA2 and with the phosphorylated C-terminus of SH2B2. Interacts with EGFR, SYK and ZAP70 via the highly conserved Cbl-N region. Also interacts with SORBS1 and INPPL1/SHIP2. Interacts with phosphorylated LAT2. May interact with CBLB (By similarity). Interacts with ALK, AXL, BLK, FGR and FGFR2. Interacts with CSF1R, EPHB1, FLT1, KDR, PDGFRA and PDGFRB; regulates receptor degradation through ubiquitination. Interacts with HCK and LYN. Interacts with TEK/TIE2 (tyrosine phosphorylated).
Subcellular Location : Cytoplasm. Cell membrane. Note=Colocalizes with FGFR2 in lipid rafts at the cell membrane.
Post-translational modifications : Phosphorylated on tyrosine residues by ALK, EGFR, SYK, FYN and ZAP70 (By similarity). Phosphorylated on tyrosine residues in response to FLT1 and KIT signaling. Phosphorylated on tyrosine residues by INSR and FGR. Phosphorylated on several tyrosine residues by constitutively activated FGFR3. Not phosphorylated at Tyr-731 by FGFR3. Phosphorylated on tyrosine residues by activated CSF1R, PDGFRA and PDGFRB. Phosphorylated on tyrosine residues by HCK. 
Ubiquitinated, leading to its degradation via the proteasome.
DISEASE : Defects in CBL are the cause of Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563]. A syndrome characterized by a phenotype reminiscent of Noonan syndrome. Clinical features are highly variable, including facial dysmorphism, short neck, developmental delay, hyperextensible joints and thorax abnormalities with widely spaced nipples. The facial features consist of triangular face with hyperorism, large low-set ears, ptosis, and flat nasal bridge. Some patients manifest cardiac defects.
Similarity : Contains 1 Cbl-PTB (Cbl-type phosphotyrosine-binding) domain.
Contains 1 RING-type zinc finger.
Contains 1 UBA domain.
質(zhì)量保證，品種zui全，價格*，了解更多抗體盡在上海一研生物科技有限公司！歡迎點擊進入！